Immunocore names David Berman as Head of R&D

Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development....

January 16, 2019 | Wednesday | News
Seres Therapeutics announces CEO transition

Microbiome therapeutics platform, Seres Therapeutics has announced the appointment of Eric D. Shaff as Preside...

January 16, 2019 | Wednesday | News
Exelixis announces USFDA approval of CABOMETYX

Oncology focused biotechnology company, Exelixis has announced that USFDA has approved CABOMETYX tablets for patients wi...

January 16, 2019 | Wednesday | News
Patient Specific 3D Printed implant set to market globally

Additive Orthopaedics, LLC., the leader in 3D printed orthopaedic foot and ankle devices, announces that is has received...

January 16, 2019 | Wednesday | News
Roche launches uPath enterprise software for digital pathology

Roche has announced the launch of its innovative uPath enterprise software for digital pathology. Offering a new standar...

January 16, 2019 | Wednesday | News
InVivo Therapeutics appoints Richard Christopher as CFO

InVivo Therapeutics Holdings Corp, a research and clinical-stage biomaterials and biotechnology company with a focus on ...

January 16, 2019 | Wednesday | News
PharmaCyte Biotech announces encapsulation of live cells for clinical trials in pancreatic cancer

PharmaCyte Biotech, a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes us...

January 16, 2019 | Wednesday | News
Walgreens, Microsoft to transform health care delivery

  Walgreens Boots Alliance Inc. (WBA) and Microsoft Corp. have joined forces to develop new health care delivery m...

January 16, 2019 | Wednesday | News
OSSIO receives FDA 510(k) clearance for OSSIOfiber Bone Pin Product Family

OSSIO, an orthopedic fixation company has announced that its OSSIOfiber Bone Pin Family has received 510(k) market clear...

January 15, 2019 | Tuesday | News
Biomunex Pharma, Sanofi to develop bi- and multi-specific antibodies

Biomunex Pharmaceuticals, a biopharmaceutical company focused on providing immuno-therapeutics through the discovery and...

January 15, 2019 | Tuesday | News
FDA approves Amplatzer Piccolo Occluder by Abbott

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved the Amplatzer Piccolo™ Occluder...

January 15, 2019 | Tuesday | News
Merck, Roche to renew global distribution agreement

Merck and Roche have agreed to renew their current distribution agreement for the Biochemical Reagents an...

January 15, 2019 | Tuesday | News
NIH starts clinical trial for FMT

A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota tr...

January 15, 2019 | Tuesday | News
CSE, Kapoor Kapital, and OTCM to co-host Canada Cannabis House

The Canadian Securities Exchange (CSE), a Canadian listing exchange recognized as a Qualified Foreign Exchange in the U....

January 14, 2019 | Monday | News
PQ Bypass raises $60M

PQ Bypass, a medical device company dedicated to advancing treatment options for patients with peripheral arterial disea...

January 14, 2019 | Monday | News
NIH team develops AI approach for cervical cancer screening

A research team led by investigators from the National Institutes of Health and Global Good has developed a computer alg...

January 14, 2019 | Monday | News
Amarantus enters commercialization treaty with IDEA Pharma for Subsidiaries

Amarantus Bioscience Holdings, Inc., a US-based JLABS-alumnus biotechnology holding company developing first-in-class or...

January 11, 2019 | Friday | News
With HIV, undetectable equals untransmittable: NIH

In recent years, an overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable...

January 11, 2019 | Friday | News